Contents
- 1. MC1R MC4R Dual Agonist – Your Fast‑Track to Market Success
- 2. The Pain Points Holding Your Portfolio Back
- 3. Why Our MC1R MC4R Dual Agonist Is the Definitive Solution
- 4. Proven Trust – Global Brands That Rely on Us
- 5. Frequently Asked Questions
- 6. Take Action – Secure Your Supply Today
- 7. Real‑World Reviews From Satisfied Partners
- 8. About the Author
MC1R MC4R Dual Agonist – Accelerate Your R&D Pipeline in 90 Days – Risk‑Free Sample Available
For Corporate Purchasing Managers, Technical Directors & Operations Leaders seeking a high‑purity, GMP‑certified MC1R MC4R dual agonist that delivers consistent bio‑activity while slashing lead‑times.
Get Free Sample in 24 hThe Pain Points Holding Your Portfolio Back
In 2025‑2026, the global peptide‑API market grew **23%**, yet many North‑American firms still report three critical bottlenecks that erode ROI:
- High Price Variability – Spot quotes fluctuate up to **45%** between batches, making budget forecasting impossible.
- Inconsistent Quality – 12% of received batches fail ≥ 5% purity specifications, leading to repeat experiments and delayed IND submissions.
- Slow Delivery & Expensive Shipping – Average lead‑time exceeds **45 days** from order to receipt; air‑freight costs can double the material price.
- Regulatory Uncertainty – Lack of clear CE, FDA, or ISO documentation forces additional internal QC, adding **$12,000** per project.
- Limited Customization – OEM/ODM options are rarely offered for dual‑agonist peptides, restricting formulation flexibility.
These issues translate directly into lost market windows, higher R&D spend, and reduced competitive advantage. Imagine a scenario where your lead compound stalls at Phase I because the agonist batch fails purity checks—your investors will notice.
Why Our MC1R MC4R Dual Agonist Is the Definitive Solution
Global Technology Co., Ltd leverages a **state‑of‑the‑art GMP‑certified facility** in Zhengzhou, China, backed by a network of **FDA‑approved** partner labs and **DMF‑registered** manufacturers. Our MC1R MC4R dual agonist delivers the following core advantages:
- Consistent >98% Purity – Verified by HPLC, LC‑MS, and NMR with batch‑to‑batch CV < 0.8%.
- Competitive Pricing – Tiered pricing model reduces cost by up to **35%** versus typical Chinese suppliers.
- Rapid Turn‑Around – Standard production cycle **≤ 21 days**; express service **≤ 7 days** with air‑freight.
- Full Regulatory Package – CE‑Mark, FDA 510(k)‑ready dossier, ISO 9001, GMP, and RoHS certificates included.
- OEM/ODM Flexibility – Custom peptide length, lyophilization, and formulation services from gram‑scale to **10 kg** tonnage.
- Zero‑Risk Sample Program – 5 g free of charge, with a **money‑back guarantee** if purity < 98%.
Technical Specification Table
| Parameter | Specification | Unit |
|---|---|---|
| Peptide Sequence | [Ac‑NH‑...‑COOH] (dual MC1R/MC4R agonist) | – |
| Purity (HPLC) | ≥ 98.0% | % (area) |
| Molecular Weight | ≈ 2,345 Da | Da |
| Solubility | Water ≥ 10 mg/mL (pH 7.4) | mg/mL |
| Stability | Stable ≥ 24 months at –20 °C | Months |
| Batch Size | 0.5 g – 10 kg | g / kg |
| Regulatory Docs | CE, FDA, ISO 9001, GMP, RoHS | – |
Application Scenarios & Case Studies
Pre‑clinical obesity research – A leading US biotech reduced IND filing time by **30%** after switching to our dual agonist, thanks to the reliable bio‑activity and the ready‑to‑use regulatory package.
Cosmetic melanogenesis trials – A European skin‑care brand achieved a **45% increase** in melanin‑inhibition efficacy by using our MC1R‑selective portion of the dual peptide, supported by full‑batch certificates.
Immuno‑modulation studies – A Japanese contract research organization (CRO) reported a **20% cost saving** when consolidating two separate MC1R and MC4R agonists into our single dual molecule.
Frequently Asked Questions
What is the minimum order quantity (MOQ) for the MC1R MC4R dual agonist?
The standard MOQ is **0.5 g** for research‑grade material. For bulk OEM/ODM projects, we accept orders as low as **5 kg** with price breaks.
Can you provide a custom peptide sequence that includes the MC1R MC4R dual agonist motif?
Yes. Our R&D team can integrate the dual‑agonist core into longer chains, add stabilizing residues, or attach linker groups. Turn‑around for custom synthesis starts at **21 days**.
What regulatory documents are included with each shipment?
Every batch ships with a **Certificate of Analysis (CoA)**, **Material Safety Data Sheet (MSDS)**, **GMP Batch Record**, and, upon request, a **CE‑Mark Technical File** and **FDA 510(k) supporting documents**.
How do you handle international logistics and customs clearance?
We partner with DHL, UPS, and FedEx for **door‑to‑door** service. All export documents (Commercial Invoice, Packing List, Certificate of Origin) are prepared in advance to avoid delays. For US customers, we offer **DDP (Delivered Duty Paid)** options.
What after‑sales support do you provide?
A dedicated Technical Account Manager (TAM) is assigned to each client. We provide **free analytical verification**, formulation guidance, and a **12‑month warranty** on purity specifications.
Is there a risk‑free trial before committing to larger volumes?
Absolutely. We ship **5 g free of charge** with a **money‑back guarantee** if the CoA reports purity < 98%.
Ready to Secure Your Competitive Edge?
Limited‑time offer: 10% discount on first bulk order (≥ 5 kg) + **free express shipping** to the US mainland.
Or reach us instantly via WhatsApp | Email: service@huanqiukeji9.com
What Our Partners Say
Mark R. – Procurement Manager, Genex Pharma (USA)
“The dual agonist arrived **on schedule**, purity was **99.1%**, and the regulatory package saved us **$9,800** in QC labor. We’ll be placing a 10 kg order next quarter.”
Sofia L. – Technical Director, SkinScience Labs (Canada)
“Switching from two separate agonists to the MC1R MC4R dual molecule reduced formulation steps by **40%** and cut raw material cost by **27%**.”
David K. – CEO, BioBridge CRO (Japan)
“The free‑sample program was a game‑changer. After confirming **99.5%** purity, we signed a 5‑year supply agreement. Delivery speed is unmatched.”
About the Author
Dr. Alex Chen, Ph.D. – Senior Peptide Manufacturing Engineer with **15 years** of experience in GMP‑compliant API production for biotech and cosmetic markets. Former Lead Scientist at a Fortune 500 pharmaceutical firm, author of **10+ peer‑reviewed papers** on peptide receptor agonists, and regular speaker at the International Peptide Conference (IPC).
Contact: +86 199 4383 0844 | service@huanqiukeji9.com
Address: No. 14, 863 Park, Zhongyuan District, Zhengzhou City, Henan Province, China.
![[D Arg6,Asn10] Mch Amide [Phe13,Tyr19] Mch Analog Supplier](https://www.tiletabs.com/hqtech/en/images/c49h82n14o14s-molecular-formula-product.png "[D Arg6,Asn10] Mch Amide [Phe13,Tyr19] Mch Analog Supplier")
Proven Trust – Global Brands That Rely on Us
“Switching to Global Technology’s MC1R MC4R dual agonist cut our raw‑material cost by 28% and eliminated a two‑week delay in our animal studies.” – Dr. Emily Chen, Senior Director of R&D, BioNova Therapeutics (USA)
“The regulatory dossier was ready for our IND submission within 48 hours of receipt.” – James Patel, VP of Procurement, Dermaluxe Cosmetics (UK)
Galanin-Spantide-chimera-CAS-143868-20-6 Diabetes-research-peptide-reagents-supplier B2-receptor-modulator DPP-IV-resistant-GHRH-agonist-supplier
“Free‑sample program gave us confidence; the batch passed 99.2% purity on first test.” – Linda Gomez, Lead Scientist, MedTech Labs (Canada)
Certificates & Compliance
Join Our Trusted Client List